Transcript Highlights:

• Brown, part of that, you talked about some of the ingredients are in your food.
• I've got to look at the labels very carefully before I make anything for him.
• To that end, in terms of the ingredients, but also ingredients that are sourced from farms.
• So that's, I think, it's really around labeling, help consumers understand.
• The yellow is kind of a paint we use to label the fats inside of the cells.

Summary: The Select Committee on Alternative Protein Innovation held its first informational hearing to examine the state of alternative protein research, industry growth, and policy needs in California. The chair opened by noting California’s $5 million public investment in UC research in 2022 and framed the hearing around three panels: the climate, environmental, and security potential of alternative proteins; industry scaling and commercialization; and university-led research and workforce development. Members emphasized that the committee will continue with site visits and additional hearings across the state. The first panel focused on the case for alternative proteins as a climate, land, water, biodiversity, and food-security solution. Shana Fertig of the Good Food Institute argued that plant-based, fermentation-derived, and cultivated proteins can reduce greenhouse gas emissions, land use, and water use while helping California meet its climate and conservation goals. Zane Swanson of CSIS added that alternative proteins could reduce risks tied to zoonotic disease, antimicrobial resistance, supply-chain disruption, and broader national security concerns. In questions, members discussed the role of pharmaceuticals in animal agriculture and how alternative proteins might complement, rather than replace, traditional farming by creating new markets for California crops and helping farmers diversify. The second panel featured industry leaders Ethan Brown of Beyond Meat, Myra Passick of Upside Foods, and Arye Elfenbein of Wildtype. Brown highlighted plant-based meat’s health and climate benefits, criticized misinformation campaigns against the sector, and urged better labeling, reduced subsidies for factory farming, and more plant-based food in public institutions. Passick described cultivated meat as a scalable food-production technology, said Upside Foods has already produced millions of pounds annually at its Emeryville facility, and asked for grants, low-interest loans, and possible participation in cap-and-trade or similar revenue programs. Elfenbein described cultivated seafood as a way to address overfishing, contamination, traceability problems, and the heavy import dependence of the U.S. seafood supply, while also noting conservation benefits and the need for California to remain a hub for the industry. The final panel centered on research and workforce development. UCLA’s Amy Rowat described state-funded work on technical bottlenecks such as growing fat cells and creating edible scaffolds, along with a Future Food Fellows program that trains students across science, engineering, law, and policy. UC Santa Cruz economist Galina Hale argued that alternative proteins are necessary to meet future protein demand while reducing food-system emissions, and said California must support the sector through grants, loans, procurement, and research centers to avoid losing leadership to other states and countries. The hearing ended with the chair thanking the witnesses, noting that all materials would be posted online, and saying the committee would continue building policy and budget proposals to support the sector.

Transcript Highlights:

• I don't understand why we don't just work on making sure that lab-grown meat is appropriately labeled
• </c><00:05:04.880><c> Um,</c> grown meat is appropriately labeled.
• Um, grown meat is appropriately labeled.
• Um, there are cell-based ingredients that are used in pet food and supplements and such.
• I think the concern has already been addressed with the labeling provision that we already had.

Keywords: Meeting Start: 00:00 Attendance Roll Call: 00:25 HB 309 Discussion: 00:49 HB 308 Roll Call Vote: 11:34, 958, all

Transcript Highlights:

• in accordance with FDA that is labeled in accordance with FDA guidelines<00:17:53.360><c> labeling</
• A 503A is reimbursed per the active ingredient. There is no per active ingredient in a 503B.
• </c> is reimbursed per the active ingredient. is reimbursed per the active ingredient.
• </c> A label alone won't solve the problem. A label alone won't solve the problem.
• So, we have labeling requirement?

Bills: HB2323, HB2324, HB1509, HB2164, HB2165, HB2367, HB2619, HB1765, HB2187, HB1864, HB1452, HB2314, HB1898, HB2558, HB2319, HB1643, HB2121

Keywords: workers' compensation, treatment plans, vocational rehabilitation, electronic submission, reporting requirements, occupational safety, hoisting machines, discrimination protection, Department of Labor, safety standards, treatment plan, injured worker, medical treatment authorization, employer response deadline, secure electronic transmission, facsimile, fax, mail submission, denial of care, medical necessity

Summary: The committee heard several administration bills related largely to workers’ compensation and unemployment insurance. On HB 2323 HD1, which would modernize workers’ compensation notice and filing procedures, DLIR and other agencies testified in support of the original bill language but said HD1 removed key components and weakened the bill’s clarity and continuity. HB 2324 HD1, which would repeal state hoisting-machine certification requirements and the separate crane operator certificate, drew support from DLIR; members asked about whether the change would affect safety or local operators, and DLIR said OSHA-compliant certifications already exist and the union supported the change. HB 1509 HD1, which would require faster employer responses to treatment plans and impose penalties for nonresponse, received support from DLIR and others, while DHRD said it wanted an amendment. The committee also took up HB 2164 HD1 on compounded prescription drugs in workers’ compensation. DLIR supported the bill as a way to define compounded drugs and curb inflated pricing, but DHRD and a medical provider opposed it and asked for amendments. Testimony focused heavily on whether the definition should include 503B compounding facilities and whether physician dispensing should be limited to the first 30 days after injury. HB 2165 HD1, dealing with unemployment insurance eligibility and removing the two-year limit on recouping overpayments, was supported by DLIR but opposed by Unite Here Local 5, which argued it would make it harder for striking workers and other claimants. Members questioned the impact of changing reporting deadlines from calendar days to business days and raised concerns about future benefit offsets; DLIR said the bill was needed for federal conformity and that the committee would revisit the offset percentage and effective date. Later, the committee heard HB 2367 on pay transparency, requiring salary ranges in job postings and removing the small-employer exemption. The Hawaii Civil Rights Commission, AAUW, Hawaii Women Lawyers, and an individual testifier supported the bill, saying pay transparency promotes fairness, trust, and pay equity; one testifier described being underpaid compared with a predecessor and said posting ranges would save applicants’ time. HB 2619 HD1, concerning homemade food products and farm kitchens, received generally supportive comments from the Department of Health, which requested an amendment to preserve flexibility in future rulemaking. HB 1765 HD1, on spear-fishing safety warnings, drew support from a safety educator and comments from DLNR; supporters said warning labels would help prevent hypoxic blackout deaths and were low-cost and easy to implement. No votes or final committee actions were taken in the portion of the meeting provided.

Transcript Highlights:

• Most compounders just test for the active ingredient.
• Chemists have found in these ingredients. That's just not safe enough for a drug that you inject.
• Every ingredient that comes into my pharmacy, I have a certificate of analysis. That's really...
• All the ingredients that are put into a compound are using those ingredients that have been reviewed.
• We also don't believe that people should be using substandard ingredients or any of those things.

Keywords: 988, house, all

Transcript Highlights:

• , the testing, the labeling, and sales of non-food substances.
• We regulate it, and we label it, and we package it safely, and keep it away from children.
• Why is no one talking about these multi-ingredient kratom products?
• It's how product is formulated, labeled, marketed, and consumed.
• And it will say right on the label how much 7-hydroxymitragynine is in the product.

Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful for consumption, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. The hearing was framed as part of ongoing legislative work, including a future review of AB 1088, and members emphasized the need to weigh potential benefits against risks and consider whether stronger safeguards are needed. Expert testimony from a toxicology professor and several public health and medical officials described kratom as a plant with multiple alkaloids, with 7-OH identified as the more potent opioid-like compound associated with tolerance, dependence, withdrawal, and respiratory depression. CDPH reported 362 kratom-related overdose deaths in California from 2019 to 2023 and 15 deaths involving 7-OH, while Los Angeles County officials described unexplained deaths in young adults that led them to expand toxicology testing and identify 7-OH as a common factor. County and state public health representatives said they have issued advisories, contacted retailers, removed products from shelves, and taken enforcement actions, but they stressed that local enforcement is patchy, under-resourced, and limited by unclear jurisdiction and lack of testing capacity. Medical witnesses said patients are presenting with 7-OH dependence and withdrawal in ways similar to fentanyl-related cases, sometimes requiring buprenorphine, methadone, or repeated naloxone. They argued that unregulated retail sales and misleading marketing make the products especially risky, and that a statewide framework would be more effective than a patchwork of local ordinances. Some officials said the safest current policy is to keep kratom and 7-OH unlawful for consumption, while others said any new regulation would need resources, packaging rules, and clearer authority for enforcement. Industry and consumer advocates urged the committee to distinguish natural kratom leaf from concentrated or synthetic 7-OH products. They argued that kratom leaf has long-standing use, that 7-OH should be targeted rather than the whole plant, and that regulation should focus on age limits, labeling, testing, serving-size caps, and restrictions on adulterated products rather than prohibition. Several speakers warned that bans could push demand to the black market and reduce access for people using the products for pain relief or harm reduction, while critics of the industry said the products are being marketed deceptively and that more comprehensive regulation is needed.

Transcript Highlights:

• And as you know, hot dogs are one of the ingredients that it could possibly end up in.
• Well, the production facilities were out of state and wasn’t regulating the ingredients.
• This here is on the same lines except this here is with labeling.
• So if we label it farm to table, that would be fine, but we don't want it to be...
• It would not be a very good label. No, sir. I agree. Thank you. Thank you. Thank you.

Summary: The Senate Committee on Agriculture, Forestry, and Rural Development met on May 12, 2026, approved the April 28 minutes, and heard extensive testimony on House Concurrent Resolution 77, which urges federal action to address labor shortages affecting Louisiana’s crawfish industry and other seasonal employers. Representative Butler, Commissioner Strain, industry representatives, landscapers, nursery operators, and Farm Bureau supporters argued that H-2A/H-2B visa limits and processing delays are hurting crawfish processors, landscapers, nurseries, and related businesses, causing lost production, higher costs, and broader economic harm. Members emphasized that the workers discussed are legal guest workers, not illegal immigration, and several senators voiced support. HCR 77 was reported favorably, with a motion to co-author also noted. The committee then considered House Bill 81 on property rights and accountability for violations. Representative Boyer presented the bill, but Senator Long asked that it be voluntarily deferred so he could work on possible amendments and improve the measure before it advances. The author agreed, and the bill was deferred. The committee also heard and acted on several bills related to agricultural policy and food systems. House Bill 512, concerning cell-cultured meat, was presented as a measure to protect livestock producers and allow continued research while prohibiting the product; after questions about research and labeling, it was reported favorably. House Bill 717, a labeling companion measure for cell-cultured meat, was also reported favorably. House Bill 1194, which would direct the LSU AgCenter to study food deserts and develop a plan, drew concern from the AgCenter over capacity and funding; members agreed to report it without action so it could be recommitted to finance and worked on further. Finally, House Bill 663, revising the membership of the Delta Economic Research and Sustainability District board, was presented on behalf of the absent author and reported favorably. The committee then adjourned.

Transcript Highlights:

• To date, the department has regulated the cultivation, manufacturing, labeling, packaging, testing, and
• DCC regulations prohibit labeling that is attractive to children, but the regulations do not prohibit
• It shows that although the labeling shows one-tenth increments, the can itself is opaque, and there's
• Well, so part of that is the formation of our team that reviews labels.
• And although there are pictures on labels, and although there are pictures on labels, they're not called

Summary: The Joint Legislative Audit Committee heard an audit on the Department of Cannabis Control’s oversight of cannabis packaging and labeling, focused on products that may be attractive to children. The auditor said the department’s rules are often vague or subjective, leading to inconsistent enforcement, and that the state relies heavily on complaints rather than pre-market review. The audit found disagreements with DCC’s conclusions in 13 of 80 packaging reviews, and noted weaknesses in tracking repeat violators and escalating penalties. The auditor recommended clearer statutory standards, better internal review tools, stronger repeat-offender policies, and consideration of options such as plain packaging or pre-approval systems. Committee members and the audit requester emphasized rising cannabis poison-control calls involving children under five and cited examples of legal products with cartoon imagery, bright colors, candy-like names, and beverage packaging that resembled ordinary drinks. DCC representatives said they had already begun reforms, including a centralized review team, improved databases, enhanced technology tools, and new procedures to track compliance history and apply progressive discipline. They also stressed that illicit cannabis and intoxicating hemp remain major sources of youth exposure and argued that some issues require both regulatory refinement and more legislative clarity. Public health witnesses argued that California has not done enough to protect children and urged plain packaging, limits on flavors and child-appealing design, and a pre-market review process. Industry representatives agreed that cannabis should not be marketed to children but said the current rules are too subjective and inconsistent, and asked for objective, bright-line standards rather than broader bans. Several members said the examples shown were plainly child-appealing and called for stronger statutory guardrails, while also acknowledging the need to keep pressure on the illicit market. No formal vote or action was taken during the hearing.

Bills: SB2088, SB2925, SB3263, SB2047, SB2087, SB2100, SB2268, SB2353, SB2781, SB2902

Keywords: coconut trees, tax credit, natural management, Hawaii, agriculture, biosecurity, environment, coconut rhinoceros beetle, student-athletes, name image likeness, NIL, compensation, transparency, University of Hawaii, Title IX, funding, protections, pharmacy benefit managers, maximum allowable cost, drug pricing

Summary: The joint committee on Ways and Means and Consumer Protection met for decision-making only on two agendas and took action on a large number of Senate bills, with no oral testimony heard. On the 1016 agenda, the committee recommended passage of measures including SB 2088, SB 2925, SB 2781, and several others, and passed a number of bills with amendments. Notable amendments included SB 3263, which adopted AG amendments related to the name, image, and likeness endowment trust fund; SB 2047 on pharmacy benefit managers, which incorporated Hawaii Pharmacist Association changes; SB 2087 on health insurance, which added Insurance Division clarifications; SB 2100 on pesticides, which added a blank appropriation; SB 2353 on outdoor signage, which removed provisions related to the Wiki special district; and SB 2902 on renewable energy, which clarified certification standards for portable solar devices and exempted them from certain disclosure requirements. Most recommendations were adopted without objection, though a few members noted reservations on selected bills. The committee also deferred one bill on the agenda, SB 3327. The committee then moved to the 1015 agenda and acted on additional measures. SB 2003 was passed with amendments tied to Act 255, including a repeal trigger if deadlines are missed; SB 2497 on utility-related transparency drew the most discussion, with one member warning about litigation and costs while another argued it was simply about electricity-rate transparency, and it ultimately passed with PUC-related amendments and an exemption for utility cooperatives. Other measures were passed unamended or with technical or fiscal amendments, including bills affecting land planning, tax credits, conveyance tax language, shoreline maintenance, and community improvement projects. Several bills had appropriations blanked or effective dates deferred to 2050, and many were adopted with members noting reservations rather than opposition. On the 1017 agenda, the committee continued approving measures, including SB 709 on crisis intervention officers and assisted community treatment, SB 2153 on defining bona fide farmer/agriculture activity, SB 2694 on water rate adjustments, SB 3025 on income eligibility limits, and SB 3085 on the Hawaii film studio, which included a five-year repeal provision if the studio has not relocated. The committee also passed numerous other bills unamended or with technical amendments, often deferring effective dates or blanking appropriations. Across both agendas, the committee’s actions were largely consistent: bills were advanced with amendments tailored to agency requests, technical corrections, or fiscal adjustments, and votes were generally unanimous or near-unanimous with occasional reservations recorded.

Transcript Highlights:

• Uh, there's one medication that has a label indication for treating postpartum depression.
• Not that the others are not, but it has a label... others are not, but it has a label indication for
• You're going to automatically go to the one that has the label indication for it.

Bills: HB322, HB346, HB336, HB384, SB237

Keywords: postpartum depression, postnatal care, maternal mental health, perinatal depression, postpartum screening, new mother, birth mother, newborn discharge, hospital discharge materials, public health education, maternal health, depression screening, health care providers, physicians, nurses, Alabama Department of Public Health, medical liability, standard of care, retired physicians, volunteer medical care

Transcript Highlights:

• close to losing exclusivity under its patent to a similar, newer drug, or maybe even one with a new label

Bills: SB1040, SB1041, SB1095, SB1096, SB1097, SB527

Keywords: drug competition, product hopping, generic drugs, biosimilars, federal regulations, FTC Act, patent, biological products, healthcare access, affordable prescriptions, Medicare, Federal Trade Commission, sham petitions, competition, public health, unfair competition, healthcare, pharmaceutical, antitrust law, pay-for-delay

Summary: The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.

Transcript Highlights:

• To date, the department has regulated the cultivation, manufacturing, labeling, packaging, testing, and
• Well, part of that is the formation of our team that reviews labels.
• And although there are pictures on labels, they're not called, and we regulate the names.
• And although there are pictures on labels, and although there are pictures on labels, they're not called
• We can have the strictest labels in the world.

Summary: The Joint Legislative Audit Committee heard an audit on the Department of Cannabis Control’s oversight of cannabis packaging and labeling, focused on whether products attractive to children are being kept out of the legal market. The auditor said the department’s rules are often vague or subjective, leading to inconsistent enforcement, and that the state relies heavily on licensees to self-police because there is no upfront review before products reach the market. The audit cited examples involving cartoon-like images, bright colors, flavor references, candy-like imagery, strain names, and beverage packaging, and recommended clearer statutory standards, possible pre-approval of packaging, better enforcement tools, and stronger tracking of repeat violators. Assemblymembers and senators largely agreed that child safety is the priority, but differed on the best policy response. Some members argued for clearer legislative limits and even plain packaging, saying products like root beer, cherry pie, and cereal-like designs are plainly appealing to children. Department officials said they had already begun reforms, including a centralized label-review team, a rubric, improved databases, and more attention to repeat violations, while also emphasizing that the illicit and intoxicating hemp markets are major sources of youth exposure and that resource constraints limit inspections. They said they are open to working with the Legislature on more specific standards and additional funding. Public witnesses split between public health and industry perspectives. A pediatrician and public health advocate urged stronger restrictions, including plain packaging, limits on flavors and potency, and a pre-market review system, arguing that vague rules have failed children. Industry representatives said they support youth protections but want bright-line, objective standards so compliant businesses can know what is allowed; they argued that most youth-targeted packaging is in the illicit market and that the legal market needs clearer rules rather than broader bans. No formal vote or committee action was taken during the hearing.

Transcript Highlights:

• Well, so part of that is the formation of our team that reviews labels.
• Well, so part of that is the formation of our team that reviews labels.
• And although there are pictures on labels, they're not called, and we regulate the names.
• We can have the strictest labels in the world.
• We can have the strictest labels in the world.

Summary: The Joint Legislative Audit Committee heard an audit on the Department of Cannabis Control’s oversight of cannabis packaging and labeling, focused on whether products are attractive to children. The auditor said the department’s rules are often vague, enforcement is inconsistent, and licensees are left to interpret standards without prior review. In a review of 80 packaging cases, the audit team disagreed with the department’s conclusions in 13 instances, and the report highlighted examples involving cartoon imagery, colorful fonts, candy-like references, flavor names, and cannabis beverages that resembled ordinary drinks. The auditor recommended clearer statutory definitions, possible consideration of plain packaging or pre-approval models like Oregon’s, better internal guidance, and stronger tracking and escalation for repeat violators. Committee members and Assembly Member Irwin emphasized the rise in poison control calls involving children under five since legalization and argued that legal-market packaging can contribute to accidental ingestion, especially when products resemble candy or drinks. Several members pressed the department on why items such as root beer, strawberry lemonade, and cherry pie strain names should be allowed if they may appeal to children. The Department of Cannabis Control responded that it has already centralized label review, added staff and technology tools, improved compliance-history tracking, and is using progressive discipline tools such as notices to comply, citations, embargoes, abatements, and license actions. The department also argued that the illicit cannabis and intoxicating hemp markets are major drivers of youth exposure and that enforcement resources must be balanced across those markets. Public health witness Dr. Lynn Silver urged stronger restrictions, including plain packaging, bans on added flavors and child-appealing imagery, lower THC limits for edibles and beverages, and a dedicated pre-market review process. Industry representatives from the California Cannabis Industry Association and the California Cannabis Operators Association agreed that youth protections are essential, but argued that clearer, objective standards are needed so compliant businesses can know the rules and enforcement can be consistent. They said most licensed products are already compliant, that the most blatant youth-targeted packaging is concentrated in the illicit market, and that the Legislature should refine definitions and guidance rather than rely on subjective case-by-case judgments. No formal vote or bill action was taken during the hearing.

Transcript Highlights:

• </c> nutrition space or in the ingredient nutrition space or in the ingredient products<00:04:53.680>
• </c> biomarkers for food for ingredient biomarkers for food for ingredient safety.<00:05:09.919><c> But
• It’s a database where we’ve compiled beverage ingredients, or common ingredients in beverages sold in
• In terms of the other ingredients, you’ve got ingredients that pass through and then other ingredients
• ><c> through</c> you've got ingredients that pass through you've got ingredients that pass through and

Keywords: 958, all

Summary: The task force met for its third meeting, approved the minutes, and heard testimony from Dr. Jack on behalf of the American Beverage Association and Kentucky Beverage Association. Dr. Jack argued that the “totality of the science” supports low- and no-calorie sweeteners as safe and useful tools for reducing sugar and calories, citing FDA and other domestic and international reviews, clinical trials, and the FDA’s recent healthy-label rule. He also described the industry’s transparency efforts, including a “Good to Know” database compiling ingredient and safety information, and said the beverage industry has voluntarily worked to offer more choices with less sugar. Members questioned him about whether beverage ingredients are restricted in other countries, possible health effects beyond weight and cancer, concerns about metabolic issues and gut microbiome effects, whether sweeteners are addictive, and why companies do not simply remove sweeteners. Dr. Jack responded that most ingredients are permitted in many jurisdictions, that broad food-safety reviews have looked at multiple endpoints and found the ingredients safe, that the gut microbiome is still being studied, and that recent clinical evidence does not show increased sweetness preference. He also said business decisions about formulations are up to companies and noted that cane sugar and high-fructose corn syrup are metabolically similar. The committee also discussed consumer apps and ingredient-scoring tools; Dr. Jack said the industry’s website presents facts without interpretation and is based on food-safety agency assessments. At the end of his testimony, the chair accepted additional fact sheets for the committee. The meeting then moved on to introduce Dr. Gary Huber, who began testimony by emphasizing integrative medicine, metabolic syndrome, and the role of diet, exercise, sleep, and stress in health, but his full presentation was not included in the excerpt.

Transcript Highlights:

• Why would talc need a warning label?
• WHY WOULD TALC NEED A WERE WHATTING LABEL?
• "Intentionally added ingredient, and then you list them, and talc is listed as one of those ingredients
• ingredients.
• My questions to deal with the warning label.

Keywords: 993, senate, all

Summary: The Senate convened, approved the journal, and then moved through a large number of motions to discharge bills from committees and substitute identical Senate bills for third reading. The chamber also received and accepted a Finance Committee report on nominations for Kathleen Mosier as Commissioner of Parks, Recreation and Historic Preservation, Terrence O’Leary as Commissioner of Homeland Security and Emergency Services, and John Kagia as Executive Director of the Office of Cannabis Management. All three nominees were confirmed, with Mosier and O’Leary confirmed unanimously and Kagia confirmed 57-1, with Senator Walczyk voting no. The Senate adopted previously approved resolutions recognizing June 2026 as LGBTQIA+ Pride Month and mourning the death of Susan Irene Wright of Harlem. Senators Brisport and Bottcher spoke at length in support of Pride Month, emphasizing LGBTQ+ history, resilience, and ongoing threats to the trans community. On the Susan Wright resolution, Senators Cleare, Bailey, and Bottcher praised her community leadership, philanthropy, and family legacy, and Assembly Member Jordan Wright was recognized in the chamber. The body then considered and passed many bills on the calendar, including measures on insurance, environmental conservation, public health, education, business law, labor, social services, highway law, and local tax exemptions. Several bills drew brief explanations of vote, including a measure to end higher insurance premiums for widows, a bill to prohibit correctional facilities from denying visitation because of menstrual products or IUDs, and a Medicaid-related bill to expand access to blood pressure monitors for pregnant people. Most bills passed with broad support, though some had notable opposition from a small group of senators. Late in the session, the Senate took up a proposed constitutional amendment on redistricting. Senator Stewart-Cousins sponsored the measure, and Senator Walczyk questioned it extensively, arguing voters had previously approved an independent redistricting process and objecting to changes that would remove the Legislature’s two-thirds map-approval requirement and alter the commission’s role. The sponsor said the changes were needed in response to aggressive partisan redistricting in other states and would still require voter ratification in future sessions. The transcript ends during that debate, with no final vote on the amendment shown.

Transcript Highlights:

• They can volunteer to start at a young age rather than label at the gas pump.
• SB 500, relating to coffee labeling, clarifying the labeling and advertising requirements for coffee
• </c><00:37:45.920><c> clarifying</c> relating to Coffee labeling clarifying relating to Coffee labeling
• c> the labeling and advertising the labeling and advertising requirements<00:37:48.200><c> for</c><00
• </c><00:38:32.040><c> on</c> starting off with s SP 1015 labels on starting off with s SP 1015 labels

Keywords: 912, senate, all

Summary: The joint AEN-PSM hearing on February 7, 2025 focused primarily on three agriculture-related measures and one animal welfare bill, with additional discussion of pesticide drift monitoring, coffee labeling, and a gas-pump labeling bill. SB 762 would create an Agricultural Crimes Council and authorize agricultural crime investigators; testimony from the Department of Agriculture, the Department of Law Enforcement, the Attorney General’s office, Hawaii Farm Bureau, Hawaii Farmers Union, and several members of the public was generally supportive, with repeated calls for stronger enforcement, community involvement, and in some cases allowing investigators to be armed. Some testifiers also urged changes to the appointment process for council members, preferring neighborhood boards or local officials over gubernatorial appointments. The committee discussed combining related agricultural crime bills and noted concerns about investigator safety in remote areas. SB 763 would establish an agriculture enforcement program within the Department of Law Enforcement and a special fund. Testimony was strongly supportive from state agencies and farm groups, with speakers emphasizing the need for more effective response to agricultural theft, poaching, and related crimes. Several public testifiers linked the bill to broader community safety and asked for clearer funding, training, coordination, performance metrics, and technology use. The committee also heard SB 1022, which would prohibit leaving pets in dangerous conditions in vehicles and allow officers, firefighters, animal control, and in some cases private citizens to rescue animals; the Attorney General said existing cruelty statutes may already cover the conduct and suggested amendments, while HPD opposed the bill. Members asked about liability for rescuers and whether the proposal might affect property-crime enforcement. The committee also heard SB 1304 on pesticide drift monitoring funding, with the Department of Agriculture supporting the measure and explaining it was needed to complete a required project under an EPA-related agreement. A Hawaii Alliance for Progressive Action representative raised concerns about the methodology of prior studies, and a public testifier described a recent odor incident near a roadway and school. SB 1015, requiring labels on gas dispensing equipment warning about fossil fuel impacts, drew support from the Department of Agriculture and the Public Utilities Commission but opposition from the Hawaii Energy Marketers Association. SB 500 on coffee labeling and regional origin was also heard, with the Department of Agriculture in support. In decision-making, the committees adopted recommendations to pass SB 762 with amendments, SB 763 with amendments, SB 1022 with technical amendments, SB 1304 with technical amendments, and SB 1015 as is; SB 500 was not acted on in the portion provided.

Transcript Highlights:

• AB 1901 would require manufacturers of children's diapers to clearly label all ingredients on both the
• It doesn't prohibit ingredients. It doesn't tell parents what diapers to choose.
• They're not asking for manufacturing processes or ingredient percentages.
• when there's an ingredient update, an ingredient hierarchy that lists ingredients using standardized
• update and a six-month window to update those ingredients online.

Summary: The committee heard AB 839, which would allow up to three sustainable aviation fuel projects to qualify for expedited CEQA judicial review. The author and airline and airport supporters argued SAF is a key emissions-reduction strategy for aviation and that California needs to signal investment certainty after prior project litigation. Environmental Justice and Earthjustice opposed, saying the bill weakens the public’s ability to challenge polluting projects and that SAF facilities can harm already overburdened communities. The committee later took a roll call on the bill and it was held on call after a 3-0 vote, with the motion being due pass to Judiciary. Members then took up AB 762, which would ban the sale of disposable nicotine vapes in California. The author and a broad coalition of waste, public health, local government, and environmental groups said the devices create fire hazards, add lithium batteries to the waste stream, and burden local recycling and hazardous waste systems. Opponents, including retailers and business groups, argued the bill would mainly affect a small legal market while the illicit market would continue to supply most disposable vapes, and warned of unintended consequences. After discussion about illicit sales, EPR ideas, and reuse alternatives, the committee voted 2-2 on the motion to pass as amended to Revenue and Taxation, so the bill was kept on call. The committee also heard AB 907, which would compensate the six local air district representatives who serve on the California Air Resources Board the same as other board members. The author and supporters said the change would improve equity and help ensure local representation on CARB, and no opposition was presented. The chair expressed support, noting similar legislation had passed the committee previously, and the bill was held for a later vote once quorum issues were resolved.

Transcript Highlights:

• it an ingredients-based rule.
• Can you expand, either of you, on what the label will say?
• My last question is: if the bill is not prescriptive in how the labeling or what the label is going to
• I mean, FDA is in charge of our label.
• So they're kind of in charge of our label.

Keywords: 987, senate, all

Transcript Highlights:

• , and it lists several ingredients.
• The FDA has specific requirements for infant formula labels.
• The information on the labels that is most helpful for caregivers includes directions for preparation
• and use, and the labels are also required to provide information that is truthful and not misleading
• So, and Missy also talked about how we have to be truthful in our labeling.

Summary: The Assembly Health Committee heard several bills focused on workforce access, consumer protection, behavioral health parity, and public health safety. AB 1591 by Assembly Member Michelle Rodriguez would create a podiatric medicine pipeline program to address shortages of podiatrists, especially in rural and underserved counties; it drew strong support from podiatrists and medical groups and no opposition. AB 2011 by Assembly Member Hart would codify federal mental health and substance use disorder parity standards into state law; supporters argued it would preserve access if federal enforcement weakens, while health plans and insurers opposed it as premature and potentially confusing. The bill was moved on a due pass motion to Appropriations and remained on call after a roll vote with several ayes and some noes. The committee also considered AB 2311 by Assembly Member Chiavo, which would allow public health care district hospitals to directly employ physicians. Supporters said the change would help district hospitals recruit and retain doctors and stabilize care in underserved communities, while CMA and emergency physicians warned it could weaken the corporate practice of medicine protections and physician autonomy. Members raised concerns about guardrails, but the author said the bill would continue to be refined; it passed on a due pass motion to the Business and Professions Committee. AB 2030 by Assembly Member Lowenthal would prohibit sales of over-the-counter diet pills and weight-loss or muscle-building supplements to minors, with supporters citing eating disorder risks and opponents objecting to scope, age-verification, and retail requirements. The bill passed on a due pass motion to the Judiciary Committee. AB 1864 by Assembly Member Berman would require screening of gene synthesis orders to prevent misuse for bioterrorism and would authorize enforcement penalties for noncompliance. Supporters from Stanford, Encode, and the medical community said the measure would align California with federal best practices and address growing biosecurity risks, while life sciences representatives raised concerns about operational burdens and supply-chain impacts. Members discussed whether the bill should include an urgency clause and how to keep the standards current; it passed to the Judiciary Committee. AB 2457 by Assembly Member Connolly would standardize and speed up Medi-Cal managed care credentialing for physicians, and it passed to Appropriations with broad support. Finally, AB 2302, presented on behalf of Assembly Member Celeste Rodriguez, would require infant formula manufacturers to test for toxic elements such as lead and arsenic and post results publicly; pediatric and disability advocates supported the measure as a transparency and infant safety bill.

Transcript Highlights:

• The label says to agricultural use user.
• You know, sometimes there's misunderstanding about a federal label and a state label. And maybe Mr.
• Every pesticide label that is approved by the EPA is unique.
• Other products like Roundup have a caution label.
• Other products like Roundup have a caution label.

Bills: HF858, HF2577, HF2576

Keywords: bioincentive payments, agriculture, job creation, environmental compliance, financial reporting, waste handling, sewage sludge, PFAS regulation, environment, record retention, fertilizer disposal, pesticide disposal, environmental impact, safety regulations, burning prohibition, 1183, house

Transcript Highlights:

• It's not just about the ingredients.
• ingredients.
• list for acne treatments or anti-aging treatments, there's a list of ingredients, as we all know.
• But there is already a process in which ingredients can be reviewed.
• specific ingredients or categories of ingredients that would like to be addressed first, and including

Keywords: 988, house, all